Researchers at Cleveland Clinic are beginning to explore the possibility of using machine learning—a subset of artificial intelligence—to customize the diets of people with irritable bowel syndrome and other gastrointestinal ailments.
One influence for this work is a small pilot study from Turkey that showed that clinicians can use ML to tailor the diets of people with IBS, improving their symptoms more effectively than with standard IBS diets (Gut Microbes 2022;14[1]:2138672).
With